# CMS Announces 2.48% Medicare Advantage Payment Rate Increase for 2027 > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medicare-advantage-payment-rate-2027-increase/ > **Published:** 2026-04-08T00:06:28-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:27:56-04:00 > **Clinical Summary:** Explore the Medicare Advantage payment rate 2027 increase and its impact on cannabis coverage and patient access in Medicare plans. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic MedicareInsurance Coverage[Healthcare Policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/)[Patient Access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/)Reimbursement Why This Matters Medicare Advantage payment rate changes directly impact coverage decisions for cannabis-related treatments and [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) to emerging therapies. This modest 2.48% increase may limit insurer willingness to cover off-label cannabis prescriptions or investigational treatments that lack robust reimbursement codes. Clinical Summary CMS announced a 2.48% payment rate increase for Medicare Advantage plans in 2027, a relatively modest adjustment that reflects ongoing healthcare cost pressures. This rate setting occurs amid growing interest in cannabis therapeutics for Medicare-eligible populations, particularly for conditions like [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), neuropathy, and cancer-related symptoms. The payment structure influences which treatments insurers will cover and how they evaluate emerging therapies without established reimbursement pathways. Dr. Caplan’s Take “For [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), this signals continued coverage challenges ahead. Medicare Advantage plans will likely remain conservative about cannabis coverage given tight margins and regulatory uncertainty around federal scheduling.” Clinical Perspective 🧠 Clinicians should expect ongoing prior authorization hurdles for cannabis recommendations in Medicare Advantage populations. Consider documenting failed conventional therapies more thoroughly and be prepared for patient cost-sharing discussions. This payment environment reinforces the importance of state [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) programs as coverage alternatives. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20CMS%20Sets%20A%202.48%25%20Medicare%20Advantage%20Payment%20Rate%20Increase%20For%202027%20%40drcaplan&url=https%3A//kffhealthnews.org/morning-breakout/cms-sets-a-2-48-medicare-advantage-payment-rate-increase-for-2027/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//kffhealthnews.org/morning-breakout/cms-sets-a-2-48-medicare-advantage-payment-rate-increase-for-2027/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20CMS%20Sets%20A%202.48%25%20Medicare%20Advantage%20Payment%20Rate%20Increase%20For%202027%20--%20via%20%40drcaplan.bsky.social%20https%3A//kffhealthnews.org/morning-breakout/cms-sets-a-2-48-medicare-advantage-payment-rate-increase-for-2027/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://kffhealthnews.org/morning-breakout/cms-sets-a-2-48-medicare-advantage-payment-rate-increase-for-2027/](https://kffhealthnews.org/morning-breakout/cms-sets-a-2-48-medicare-advantage-payment-rate-increase-for-2027/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [Does this relate to Medicare coverage for cannabis treatments?](#Does_this_relate_to_Medicare_coverage_for_cannabis_treatments) - [How does this affect insurance coverage for medical cannabis?](#How_does_this_affect_insurance_coverage_for_medical_cannabis) - [What healthcare policy implications does this have?](#What_healthcare_policy_implications_does_this_have) - [How might this impact patient access to medical cannabis?](#How_might_this_impact_patient_access_to_medical_cannabis) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests emerging findings or policy developments that healthcare professionals should monitor closely. #### Does this relate to Medicare coverage for cannabis treatments? Yes, based on the Medicare tag, this appears to involve developments regarding Medicare’s approach to cannabis-related healthcare coverage. This could significantly impact patient access for Medicare beneficiaries seeking cannabis treatments. #### How does this affect insurance coverage for medical cannabis? The insurance coverage tag indicates this news involves changes or developments in how insurance plans handle [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) reimbursement. This could represent shifts in coverage policies that affect patient out-of-pocket costs. #### What healthcare policy implications does this have? As a [healthcare policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/) development, this likely involves regulatory or administrative changes affecting how medical cannabis is covered or accessed within the healthcare system. Such policy shifts can have widespread impacts on treatment availability. #### How might this impact patient access to medical cannabis? The patient access tag suggests this development could either improve or restrict how patients obtain medical cannabis treatments. Changes in Medicare or insurance coverage policies directly affect treatment accessibility and affordability for patients. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis Insurance and the Fight for Patient Access](https://cedclinic.com/cannabis-insurance-and-the-fight-for-patient-access-sponsored-rutlandherald-com/) Explore ongoing challenges and developments in insurance coverage for cannabis patients, highlighting patient access issues. [Read More](https://cedclinic.com/cannabis-insurance-and-the-fight-for-patient-access-sponsored-rutlandherald-com/) [New Clinical Insights on Cannabis and Patient Outcomes](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) Discover recent clinical findings that impact patient outcomes and inform cannabis treatment policies. [Explore Insights](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) [Healthcare Professionals Agree Cannabis Has "Legitimate Therapeutic Uses"](https://cedclinic.com/healthcare-professionals-agree-cannabis-has-legitimate-therapeutic-uses/) Learn about the growing consensus among healthcare providers regarding the therapeutic benefits of cannabis. [Learn More](https://cedclinic.com/healthcare-professionals-agree-cannabis-has-legitimate-therapeutic-uses/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).